|
gptkb:P09056
|
gptkb:Osimertinib
|
|
gptkb:ERBB1
|
head and neck cancer
|
|
gptkb:Janus_kinase_2,_non-receptor_tyrosine_kinase
|
gptkb:fedratinib
|
|
gptkb:GLP-1_receptor
|
antidiabetic drugs
|
|
gptkb:Cdk6
|
gptkb:ribociclib
|
|
gptkb:sphingosine-1-phosphate_receptor_1
|
gptkb:siponimod
|
|
gptkb:FGFR3_gene
|
gptkb:erdafitinib
|
|
gptkb:P00533
|
gptkb:afatinib
|
|
gptkb:IDH1_gene
|
gptkb:AG-120
|
|
gptkb:CD332
|
gptkb:Rogaratinib
|
|
gptkb:HGNC:3775
|
gptkb:trastuzumab
|
|
gptkb:AKT_signaling_pathway
|
metabolic disorders
|
|
gptkb:CHRM3
|
yes
|
|
gptkb:interleukin-5_receptor
|
gptkb:reslizumab
|
|
gptkb:GABA-A_receptor_complex
|
anxiolytics
|
|
gptkb:CD332
|
gptkb:BGJ398
|
|
gptkb:CFTR_protein
|
gptkb:ivacaftor
|
|
gptkb:Bruton_tyrosine_kinase
|
zanubrutinib
|
|
gptkb:MMP2
|
inhibitors under investigation for cancer and fibrosis
|
|
gptkb:programmed_cell_death_protein_1
|
gptkb:sintilimab
|